Milestone Pharmaceuticals MIST
NASDAQ MIST
$0.72 +0.02 (+3.09%)
As of: Oct 22, 2026 · 11:44 AM EDT

Milestone Pharmaceuticals (MIST) EBT Margin (2021 - 2022)

Updated

Milestone Pharmaceuticals (MIST) recorded EBT Margin of -1002.00% in Q3 2022.

Analysis

Milestone Pharmaceuticals (MIST) EBT Margin (2021 - 2022) Analysis & Trends

On a TTM basis, Milestone Pharmaceuticals' EBT Margin came in at -381.48% as of Sep 30, 2022; for FY2021, it came in at -285.69%.

  • The Q3 2022 figure is the highest quarterly EBT Margin since Q2 2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin (Qtr)
1 Eli Lilly 1,172.00 Bn 1,140.58 Bn 19.71 Bn 40.25%
2 Johnson & Johnson 639.12 Bn 557.64 Bn 17.26 Bn 26.66%
3 AbbVie 502.23 Bn 475.34 Bn 12.70 Bn 25.18%
4 Merck 375.29 Bn 329.67 Bn 12.21 Bn -4.11%
5 Novartis Ag 302.99 Bn 266.98 Bn 11.24 Bn 29.63%
6 Astrazeneca 268.68 Bn 242.36 Bn 12.86 Bn 18.19%
7 Amgen 242.24 Bn 197.64 Bn 7.24 Bn 27.53%
8 Gilead Sciences 193.36 Bn 167.56 Bn 6.22 Bn -131.41%
9 Pfizer 172.57 Bn 119.21 Bn 10.94 Bn -4.34%
10 Milestone Pharmaceuticals 99.07 Mn -71.53 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2022 -1,002.00%
Jun 30, 2022 -10,636.71%
Jun 30, 2021 5.13%
API Access

Milestone Pharmaceuticals EBT Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebt-margin&ticker=MIST&period=max&api_key=YOUR_API_KEY